Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Psoriasis Patients and Comorbid Type 2 Diabetes: A Population-based Target Trial Emulation

Published: 25 June 2025| Version 1 | DOI: 10.17632/c7f42rb239.1
Contributors:
Debby Cheng, Helen Ji, Nicholas Theodosakis, Megan Noe, Steven Chen, Kevin Ma

Description

Supplemental data for the manuscript "Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Psoriasis Patients and Comorbid Type 2 Diabetes: A Population-based Target Trial Emulation"

Files

Institutions

  • Brigham and Women's Hospital
  • Harvard Medical School
  • Massachusetts General Hospital

Categories

Diabetes, General Dermatology, Medical Dermatology, Psoriasis, Comorbidity

Licence